CVS Health Corporation
CVS · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $95,669,910 | $87,328,680 | $85,432,750 | $56,516,510 |
| - Cash | $9,155,000 | $11,787,000 | $10,076,000 | $8,586,000 |
| + Debt | $81,752,000 | $82,724,000 | $81,213,000 | $82,920,000 |
| Enterprise Value | $168,266,910 | $158,265,680 | $156,569,750 | $130,850,510 |
| Revenue | $102,871,000 | $98,915,000 | $94,588,000 | $97,710,000 |
| % Growth | 4% | 4.6% | -3.2% | – |
| Gross Profit | $13,806,000 | $13,593,000 | $14,396,000 | $12,899,000 |
| % Margin | 13.4% | 13.7% | 15.2% | 13.2% |
| EBITDA | -$1,564,000 | $3,581,000 | $4,556,000 | $4,027,000 |
| % Margin | -1.5% | 3.6% | 4.8% | 4.1% |
| Net Income | -$3,975,000 | $1,021,000 | $1,779,000 | $1,644,000 |
| % Margin | -3.9% | 1% | 1.9% | 1.7% |
| EPS Diluted | -3.13 | 0.8 | 1.41 | 1.3 |
| % Growth | -491.3% | -43.3% | 8.5% | – |
| Operating Cash Flow | $796,000 | $1,897,000 | $4,556,000 | $1,860,000 |
| Capital Expenditures | -$698,000 | -$607,000 | -$743,000 | -$768,000 |
| Free Cash Flow | $98,000 | $1,290,000 | $3,813,000 | $1,092,000 |